Cargando…
Development of a Tumor-Selective Approach to Treat Metastatic Cancer
BACKGROUND: Patients diagnosed with metastatic cancer have almost uniformly poor prognoses. The treatments available for patients with disseminated disease are usually not curative and have side effects that limit the therapy that can be given. A treatment that is selectively toxic to tumors would m...
Autores principales: | Aboody, Karen S., Bush, Rebecca A., Garcia, Elizabeth, Metz, Marianne Z., Najbauer, Joseph, Justus, Kristine A., Phelps, Doris A., Remack, Joanna S., Yoon, Karina Jin, Gillespie, Shanna, Kim, Seung U., Glackin, Carlotta A., Potter, Philip M., Danks, Mary K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762394/ https://www.ncbi.nlm.nih.gov/pubmed/17183650 http://dx.doi.org/10.1371/journal.pone.0000023 |
Ejemplares similares
-
ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma
por: Yoon, Karina Jin, et al.
Publicado: (2008) -
Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies
por: Frank, Richard T., et al.
Publicado: (2009) -
Cellular Host Responses to Gliomas
por: Najbauer, Joseph, et al.
Publicado: (2012) -
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
por: Gutova, Margarita, et al.
Publicado: (2007) -
Concise Review: Stem Cells As an Emerging Platform for Antibody Therapy of Cancer
por: Frank, Richard T, et al.
Publicado: (2010)